Mutational Spectrum in Clinically Aggressive Low-Grade Serous Carcinoma/Serous Borderline Tumors of the Ovary

被引：0
|
作者：
Yoon, Ju-Yoon [1 ]
Devins, Kyle [2 ]
Ko, Emily [3 ]
Burger, Robert [2 ]
Reyes, Carolina [4 ]
Drapkin, Ronny [1 ]
Schwartz, Lauren [5 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] Univ Penn Hlth Syst, Philadelphia, PA USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Bala Cynwyd, PA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1224
引用
收藏
页码：1164 / 1165
页数：2
相关论文
共 50 条
  • [31] Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma
    Shvartsman, Hyun S.
    Sun, Charlotte C.
    Bodurka, Diane C.
    Mahajan, Vrinda
    Crispens, Marta
    Lu, Karen H.
    Deavers, Michael T.
    Malpica, Anais
    Silva, Elvio G.
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 625 - 629
  • [32] The development of high-grade serous carcinoma from atypical proliferative (Borderline) serous tumors and low-grade micropapillary serous carcinoma - A morphologic and molecular genetic analysis
    Dehari, R.
    Kurman, R. J.
    Logani, S.
    Shih, I.
    MODERN PATHOLOGY, 2007, 20 : 194A - 194A
  • [33] The development of high-grade serous carcinoma from atypical proliferative (Borderline) serous tumors and low-grade micropapillary serous carcinoma - A morphologic and molecular genetic analysis
    Dehari, R.
    Kurman, R. J.
    Logani, S.
    Shih, I.
    LABORATORY INVESTIGATION, 2007, 87 : 194A - 194A
  • [34] The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma - A morphogic and molecular genetic analysis
    Dehari, Reiko
    Kurman, Robert J.
    Logani, Sanjay
    Shih, Ie-Ming
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (07) : 1007 - 1012
  • [35] Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer
    Krishnan, Rahul
    Bilecz, Agnes
    Herbst, Paula
    Shimizu, Aasa
    Schweizer, Lisa
    Jaeger, Ellen
    Godden, Jen
    Stoppler, Melissa
    Yamada, Diane
    Lengyel, Ernst
    CANCER RESEARCH, 2024, 84 (05)
  • [36] Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
    Sadlecki, Pawel
    Grzanka, Dariusz
    Grabiec, Marek
    DISEASE MARKERS, 2018, 2018
  • [37] Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
    Schmeler, Kathleen M.
    Sun, Charlotte C.
    Bodurka, Diane C.
    Deavers, Michael T.
    Malpica, Anals
    Coleman, Robert L.
    Ramirez, Pedro T.
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : 510 - 514
  • [38] GLOBAL VARIATIONS IN THE MANAGEMENT OF LOW-GRADE SEROUS CARCINOMA OF THE OVARY
    Dash, Biswajit
    Bhandoria, Geetu
    Gulia, Seema
    Patil, Akshay
    Maheshwari, Amita
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A21 - A22
  • [39] Recurrent low-grade serous carcinoma of the ovary is relatively chemoresistant
    Gershenson, D. M.
    Sun, C.
    Bodurka, D.
    Coleman, R. L.
    Lu, K. H.
    Sood, A. K.
    Kavanagh, J. J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S5 - S5
  • [40] Is invasive micropapillary serous carcinoma a low-grade serous carcinoma?
    Ohishi, Y.
    Aman, M.
    Oda, Y.
    VIRCHOWS ARCHIV, 2016, 469 : S110 - S110
12345